An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)

Phelan McDermid syndrome

A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism Effectiveness of Recombinant Human Growth Hormone Therapy for Children With Phelan-McDermid Syndrome An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001) Mapping the Phenotype in Adults With Phelan-McDermid Syndrome Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome) Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome. AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy Growth Hormone Treatment in Children With Phelan McDermid Syndrome Mitochondrial Dysfunction in Phelan-McDermid Syndrome: Explaining Clinical Variation and Providing a Path Towards Treatment